Patrick J. Mahaffy

Biography

 Mr. Patrick J. Mahaffy, M.A., co-founded Clovis Oncology, Inc. on April 20, 2009 and has been its Chief Executive Officer and President since April 20, 2009. Mr. Mahaffy served as the Chief Executive Officer of Pharmion GmbH. He founded Pharmion LLC in August 1999 and served as its Chief Executive Officer and President since August 1999. Mr. Mahaffy is credited for developing corporate partnerships with Eli Lilly and Co., Systemix/Sandoz, Schering AG and Becton, Dickinson and Co. He serves as the Chairman of Gritstone Oncology Inc. He has been the Chairman of Flexion Therapeutics, Inc. (formerly, Flexion Development Partners, Inc) since 2009 and Orexigen Therapeutics, Inc. since April 2016. He served as the Chairman of Psyadon Pharmaceuticals, Inc He serves as a Trustee of Lewis and Clark College. He served as a Director of Psyadon Pharmaceuticals, Inc. Mr. Mahaffy received a B.A. in International Affairs from Lewis and Clark College and an M.A. in International Affairs from Columbia University.  

Research Interest

 Business Analysis.